CD4 and neoplasm: Deficiency of miR-17-92 cluster in CD4+ T cells significantly impairs the Th1 cells response to B16 tumor cells, including a decrease in Th1 cells number and IFN-γ production and impairment in the ability of CD4+ T cells to help CD8+ T cells.